Anterior Segment and Corneal Parameters in Keratoconus and High Myopic Astigmatism Using Schiempflug Imaging
Launched by ASSIUT UNIVERSITY · Dec 16, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two eye conditions: keratoconus and high myopic astigmatism. The goal is to use a special imaging technique called Scheimpflug tomography to look at and compare the shapes and features of the cornea (the clear front part of the eye) in people with these conditions. Researchers want to find out what distinguishes keratoconus from high myopic astigmatism, which is important for better diagnosis and treatment.
To participate in this study, you may be eligible if you have keratoconus or a clear cornea with high myopic astigmatism. However, you cannot have had previous eye surgery, other eye diseases, or wear contact lenses. If you join the study, you can expect to undergo some imaging tests to help gather information about your eye condition. Please note that the trial is not yet recruiting, so more details will be provided once it starts.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • keratoconus patient
- • virgin clear cornea with high myopic astigmatism
- • normal cornea with high myopic astigmatism
- Exclusion Criteria:
- • patients had previous ocular surgery
- • ocular diseases rather than keratoconus
- • contact lens wearer
- • corneal opacity and corneal dystrophy
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, Asyut, Egypt
Patients applied
Trial Officials
Momen Aly, lecturer
Study Director
Assiut University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported